2024 年 Citeline 奖表彰了 TrialWire 的快速患者招募平台在临床试验中最佳使用 AI 的能力。 2024 Citeline Awards recognizes TrialWire's Rapid Patient Recruitment Platform for best AI use in clinical trials.

TrialWire 的快速患者招募平台是一种按注册人数付费的人工智能解决方案，它是 2024 年 Citeline 奖的多项奖项入围者，因其在临床试验、面向患者的技术和面向赞助商的技术中对人工智能的最佳运用而获得认可。 TrialWire's Rapid Patient Recruitment Platform, a pay-per-enrolled AI-powered solution, is a multi-award finalist in the 2024 Citeline Awards, recognized for its best use of AI in clinical trials, patient-facing technology, and sponsor-facing technology. 该平台加快了患者招募速度，减少了沟通延迟，并有助于重启停滞的试验。 The platform speeds up patient recruitment, reduces communication delays, and helps reboot stalled trials.

文章

ForexTV

AsiaOne

TMCnet

Finanz Nachrichten

MENAFN

-- 显示更少 --

相关故事